MedTech News
.................... by Andrew Celentano
ReCerf Receives its CE Mark, Advancing Access to Ceramic Hip Resurfacing Across Europe
LEATHERHEAD, England, July 3, 2025 /PRNewswire/ — MatOrtho® is proud to announce that the ReCerf® Hip Resurfacing Arthroplasty (HRA) has received its CE mark, confirming compliance with European safety and performance standards. This important milestone expands access to hip resurfacing, enabling wider availability across the UK, Europe and internationally where CE marking supports market access.
ANA5 Funnel Catheter by ANACONDA Biomed Gets CE Mark, Unlocking New Era in Stroke Thrombectomy
In a recent conversation with MedTech Spectrum, Trent Reutiman, CEO of ANACONDA Biomed, shared insights into the company’s CE Mark approval for the ANA5 Funnel Catheter—a next-generation device designed to improve clot capture and procedural outcomes in acute ischemic stroke treatment.
Mimicking the benefits of exercise with a single molecule
Capital Medical University, in collaboration with the Chinese Academy of Sciences, reports that betaine, a molecule produced in the kidney and enhanced through sustained exercise, operates as a potent inhibitor of inflammatory and aging-related pathways.
Wearable X-ray-detecting fabric offers a flexible alternative to current imaging tech
Since their discovery by Wilhelm Roentgen in 1895, X-rays have become a staple of modern medical care, from imaging teeth and broken bones to screening for the early signs of breast cancer.
Scientists create first mini-lungs with built-in blood vessels, unlocking new insights for pulmonary vascular disease
UCLA researchers have successfully grown miniature lungs from stem cells—complete with their own functioning blood vessel networks.
New cell signaling pathway found to shield blood vessels from hypertension damage
By creating artificial aging in mice, researchers at Lund University in Sweden have been able to track the formation of aneurysms in the walls of blood vessels.
Coupling two methods opens up new possibilities in early detection of colorectal cancer
The number of colorectal cancer cases in people under 50 is rising worldwide, especially in high-income countries. Possible causes include Western diets, obesity, lack of exercise, and the use of antibiotics, especially in early life and adolescence.
Engineered cell cross-talk unlocks CAR-T potential against glioblastoma
A team of researchers from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET, Milan), led by Nadia Coltella and Luigi Naldini, has unveiled a powerful strategy to rejuvenate the effectiveness of chimeric antigen receptor (CAR) T cell therapy against glioblastoma, one of the most lethal and treatment-resistant brain tumors.